Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The product is now approved and available for sale to the public, replacing its previous status of being available only outside the clinical trial.
    Difference
    0.2%
    Check dated 2024-12-22T08:32:50.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-15T01:26:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.
    Difference
    1%
    Check dated 2024-12-07T23:09:26.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Several links related to thyroid cancer and neuroendocrine tumors have been removed, including resources from MedlinePlus and Dailymed, which may impact access to important medical information.
    Difference
    3%
    Check dated 2024-11-23T06:50:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding numerous resources related to thyroid cancer and neuroendocrine tumors, including links to MedlinePlus, DailyMed, and clinical trial documents.
    Difference
    3%
    Check dated 2024-11-08T19:40:47.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.0%
    Check dated 2024-11-01T12:02:48.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.